Neulogy

What is Neulogy?

Neulogy is a venture capital fund headquartered in Slovakia, focusing on seed stage investments in the Central and Eastern Europe region. They are dedicated to identifying and nurturing innovative startups, particularly those operating in the fields of deep technology, climate, health, medtech, cyber security, cleantech, B2B SaaS, and marketplace platforms.

Neulogy VC distinguishes itself by not simply following market hype but by investing in 'real innovation' which can leverage the local engineering talent.

Their portfolio showcases a variety of ventures that include an RNAseq analysis platform for treating rare genetic disorders, a digital platform for medical diagnosis, an online eyewear retailer, cybersecurity services, geothermal technology development, electric vehicle charging infrastructure, and market research solutions.

Neulogy proudly operates with a founder-friendly approach, realizing the importance of thorough questioning and providing entrepreneurs with the autonomy to discover optimal solutions for their businesses. By offering resources, expertise, and an extensive network, Neulogy VC plays a critical role in accelerating the growth of startups.

Their commitment to innovation is matched by a genuine interest in the entrepreneurial journey, ensuring a focus on each company's story and not just aggregated portfolio returns. Supported by Neulogy, startups like GA Drilling and GroupSolver were able to move beyond idea stages and develop into mature businesses. With the ethos of being entrepreneurs themselves, Neulogy's team is always ready to lend outside-the-box advice and provide strategic and business decision-making support, aiming for sustainable success in the innovative ventures they back.